InBody Co.Ltd - Asset Resilience Ratio
InBody Co.Ltd (041830) has an Asset Resilience Ratio of 20.98% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read InBody Co.Ltd (041830) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2024)
This chart shows how InBody Co.Ltd's Asset Resilience Ratio has changed over time. See shareholders equity of InBody Co.Ltd for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down InBody Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see InBody Co.Ltd (041830) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩66.79 Billion | 20.98% |
| Total Liquid Assets | ₩66.79 Billion | 20.98% |
Asset Resilience Insights
- Good Liquidity Position: InBody Co.Ltd maintains a healthy 20.98% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
InBody Co.Ltd Industry Peers by Asset Resilience Ratio
Compare InBody Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Elbit Med Tech
TA:EMTC |
Healthcare Equipment & Supplies | 7.83% |
|
Value Added Technology Co. Ltd
KQ:043150 |
Healthcare Equipment & Supplies | 3.34% |
|
i-SENS Inc
KQ:099190 |
Healthcare Equipment & Supplies | 6.17% |
|
MEDIANA Co.Ltd
KQ:041920 |
Healthcare Equipment & Supplies | 39.47% |
|
INFINITT Healthcare Co. Ltd
KQ:071200 |
Healthcare Equipment & Supplies | 61.76% |
|
Sewoon Medical Co. Ltd
KQ:100700 |
Healthcare Equipment & Supplies | 9.67% |
|
Meta Biomed Co. Ltd
KQ:059210 |
Healthcare Equipment & Supplies | 11.86% |
|
MEKICS Co Ltd
KQ:058110 |
Healthcare Equipment & Supplies | 5.91% |
Annual Asset Resilience Ratio for InBody Co.Ltd (2011–2024)
The table below shows the annual Asset Resilience Ratio data for InBody Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 33.92% | ₩103.72 Billion ≈ $70.29 Million |
₩305.82 Billion ≈ $207.25 Million |
-2.14pp |
| 2023-12-31 | 36.06% | ₩98.97 Billion ≈ $67.07 Million |
₩274.46 Billion ≈ $186.00 Million |
+0.39pp |
| 2022-12-31 | 35.66% | ₩86.55 Billion ≈ $58.65 Million |
₩242.67 Billion ≈ $164.45 Million |
+0.61pp |
| 2021-12-31 | 35.06% | ₩71.43 Billion ≈ $48.41 Million |
₩203.76 Billion ≈ $138.09 Million |
+0.45pp |
| 2020-12-31 | 34.60% | ₩57.49 Billion ≈ $38.96 Million |
₩166.15 Billion ≈ $112.60 Million |
+7.68pp |
| 2019-12-31 | 26.92% | ₩41.70 Billion ≈ $28.26 Million |
₩154.90 Billion ≈ $104.98 Million |
+7.58pp |
| 2018-12-31 | 19.34% | ₩25.47 Billion ≈ $17.26 Million |
₩131.69 Billion ≈ $89.24 Million |
-24.16pp |
| 2017-12-31 | 43.50% | ₩48.74 Billion ≈ $33.03 Million |
₩112.02 Billion ≈ $75.92 Million |
+5.15pp |
| 2016-12-31 | 38.35% | ₩37.22 Billion ≈ $25.22 Million |
₩97.06 Billion ≈ $65.78 Million |
+5.51pp |
| 2015-12-31 | 32.83% | ₩27.10 Billion ≈ $18.36 Million |
₩82.53 Billion ≈ $55.93 Million |
-6.27pp |
| 2014-12-31 | 39.11% | ₩24.70 Billion ≈ $16.74 Million |
₩63.17 Billion ≈ $42.81 Million |
+6.65pp |
| 2013-12-31 | 32.46% | ₩17.42 Billion ≈ $11.81 Million |
₩53.67 Billion ≈ $36.37 Million |
-8.55pp |
| 2012-12-31 | 41.01% | ₩19.75 Billion ≈ $13.38 Million |
₩48.16 Billion ≈ $32.64 Million |
-1.29pp |
| 2011-12-31 | 42.30% | ₩18.55 Billion ≈ $12.57 Million |
₩43.85 Billion ≈ $29.72 Million |
-- |
About InBody Co.Ltd
InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was foun… Read more